Ib-IIIb NSCLC
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Monitoring the Efficacy of Duvalizumab Combined With Neoadjuvant Chemotherapy for Ib-IIIb NSCLC by Sequencing of Immune Receptor Repertoire: a Prospective, One Arm Clinical Study (NCT04897386) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2021-06-01 |
Track Ib-IIIb NSCLC automatically
Every clearance here is in the API, with alerts when new ones post.